mRECIST criteria to assess recurrent thyroid carcinoma treatment response after radiofrequency ablation: a prospective study
ConclusionRFA is a safe procedure to treat the viable tumour tissue and to reduce the RTC volume; as to the criteria to assess treatment response, mRECIST appears to be more accurate.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Endocrinology | Laryngeal Cancer | Study | Thyroid | Thyroid Cancer